Robert Deuson

2.5k total citations
48 papers, 1.9k citations indexed

About

Robert Deuson is a scholar working on Hematology, Surgery and Genetics. According to data from OpenAlex, Robert Deuson has authored 48 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 13 papers in Surgery and 10 papers in Genetics. Recurrent topics in Robert Deuson's work include Platelet Disorders and Treatments (18 papers), Nausea and vomiting management (12 papers) and Blood groups and transfusion (10 papers). Robert Deuson is often cited by papers focused on Platelet Disorders and Treatments (18 papers), Nausea and vomiting management (12 papers) and Blood groups and transfusion (10 papers). Robert Deuson collaborates with scholars based in United States, Germany and France. Robert Deuson's co-authors include Panagiotis Mavros, Mogens Hansen, Brigitte Bloechl‐Daum, Jørn Herrstedt, Giorgio Cruciani, Bruno Daniele, Edward Rubenstein, Gérard de Pouvourville, Gedske Daugaard and Olga Geling and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Robert Deuson

45 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Deuson United States 19 1.1k 615 441 210 184 48 1.9k
X-O Shu United States 18 131 0.1× 251 0.4× 772 1.8× 490 2.3× 164 0.9× 23 1.8k
Kulasiri A. Gunawardena United Kingdom 17 307 0.3× 334 0.5× 174 0.4× 61 0.3× 34 0.2× 31 1.4k
Manjusha Nair India 23 279 0.3× 117 0.2× 78 0.2× 414 2.0× 68 0.4× 96 1.6k
Véred Abitbol France 24 413 0.4× 72 0.1× 92 0.2× 176 0.8× 111 0.6× 66 1.7k
Palle Bager Denmark 19 311 0.3× 86 0.1× 330 0.7× 140 0.7× 57 0.3× 46 1.2k
Susan Lerner United States 21 897 0.8× 67 0.1× 67 0.2× 169 0.8× 32 0.2× 44 1.9k
Mary Morgan United States 16 171 0.2× 86 0.1× 206 0.5× 195 0.9× 118 0.6× 32 1.1k
Nicolas Williet France 22 585 0.5× 68 0.1× 249 0.6× 328 1.6× 51 0.3× 70 2.2k
José Pórtoles Spain 21 262 0.2× 65 0.1× 619 1.4× 67 0.3× 105 0.6× 143 1.8k
Deborah D. Proctor United States 21 562 0.5× 66 0.1× 79 0.2× 158 0.8× 47 0.3× 66 1.6k

Countries citing papers authored by Robert Deuson

Since Specialization
Citations

This map shows the geographic impact of Robert Deuson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Deuson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Deuson more than expected).

Fields of papers citing papers by Robert Deuson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Deuson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Deuson. The network helps show where Robert Deuson may publish in the future.

Co-authorship network of co-authors of Robert Deuson

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Deuson. A scholar is included among the top collaborators of Robert Deuson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Deuson. Robert Deuson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Dawn, et al.. (2013). Cost Effectiveness of Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in Ireland. Applied Health Economics and Health Policy. 11(5). 457–469. 21 indexed citations
2.
Stasi, Roberto, Marc Michel, Jean‐François Viallard, et al.. (2012). Evaluation of bleeding-related episodes in patients with immune thrombocytopenia (ITP) receiving romiplostim or medical standard of care. International Journal of Hematology. 96(1). 26–33. 18 indexed citations
3.
4.
Kuter, David J., Susan D. Mathias, Mathias Rummel, et al.. (2012). Health‐related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care. American Journal of Hematology. 87(5). 558–561. 65 indexed citations
5.
Klaassen, Robert J., Susan D. Mathias, George R. Buchanan, et al.. (2011). Pilot study of the effect of romiplostim on child health‐related quality of life (HRQoL) and parental burden in immune thrombocytopenia (ITP). Pediatric Blood & Cancer. 58(3). 395–398. 39 indexed citations
6.
Iskedjian, Michaël, et al.. (2011). Elicitation of utility scores in Canada for immune thrombocytopenia treated with romiplostim or watch and rescue. Journal of Medical Economics. 15(2). 313–331. 3 indexed citations
7.
Szende, Ágota, John Brazier, Caroline Schaefer, et al.. (2010). Measurement of utility values in the UK for health states related to immune thrombocytopenic purpura. Current Medical Research and Opinion. 26(8). 1893–1903. 11 indexed citations
8.
Moons, Philip, et al.. (2008). Impact of corticosteroid-related symptoms in patients with immune thrombocytopenic purpura: Results of a survey of 985 patients. Clinical Therapeutics. 30(8). 1540–1552. 13 indexed citations
9.
Kantarjian, Hagop M., Francis J. Giles, Alan F. List, et al.. (2007). The incidence and impact of thrombocytopenia in myelodysplastic syndromes. Cancer. 109(9). 1705–1714. 176 indexed citations
10.
Lordick, Florian, B. Ehlken, Angela Ihbe‐Heffinger, et al.. (2006). Health outcomes and cost-effectiveness of aprepitant in outpatients receiving antiemetic prophylaxis for highly emetogenic chemotherapy in Germany. European Journal of Cancer. 43(2). 299–307. 41 indexed citations
11.
Ballatori, Enzo, Fausto Roila, Benedetta Ruggeri, et al.. (2006). The cost of chemotherapy-induced nausea and vomiting in Italy. Supportive Care in Cancer. 15(1). 31–38. 25 indexed citations
12.
Ballatori, Enzo, Fausto Roila, Benedetta Ruggeri, et al.. (2006). The impact of chemotherapy-induced nausea and vomiting on health-related quality of life. Supportive Care in Cancer. 15(2). 179–185. 106 indexed citations
13.
Liau, Chi‐Ting, et al.. (2005). Incidence of chemotherapy-induced nausea and vomiting in Taiwan: physicians’ and nurses’ estimation vs. patients’ reported outcomes. Supportive Care in Cancer. 13(5). 277–286. 60 indexed citations
14.
Lachaîne, Jean, et al.. (2005). Chemotherapy-Induced Emesis: Quality of Life and Economic Impact in the Context of Current Practice in Canada. PubMed. 2(3). 181–187. 40 indexed citations
15.
Ihbe‐Heffinger, Angela, B. Ehlken, Karin Berger, et al.. (2004). The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers. Annals of Oncology. 15(3). 526–536. 113 indexed citations
16.
Grunberg, Steven M., Robert Deuson, Panagiotis Mavros, et al.. (2004). Incidence of chemotherapy‐induced nausea and emesis after modern antiemetics. Cancer. 100(10). 2261–2668. 358 indexed citations
17.
Deuson, Robert, Kimberly G. Brodovicz, Lawrence Barker, Fangjun Zhou, & Gary L. Euler. (2001). Economic Analysis of a Child Vaccination Project Among Asian Americans in Philadelphia, Pa. Archives of Pediatrics and Adolescent Medicine. 155(8). 909–909. 18 indexed citations
18.
Deuson, Robert, Edward Hoekstra, Rebecca L. Sedjo, et al.. (1999). The Denver school-based adolescent hepatitis B vaccination program: a cost analysis with risk simulation.. American Journal of Public Health. 89(11). 1722–1727. 36 indexed citations
19.
Jacobson, Sheldon H., Edward C. Sewell, Robert Deuson, & Bruce G. Weniger. (1999). An integer programming model for vaccine procurement and delivery for childhood immunization: a pilot study. Health Care Management Science. 2(1). 1–9. 46 indexed citations
20.
Deuson, Robert. (1988). Agricultural development principles. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by X-O Shu Breakdown of academic impact, for papers by Kulasiri A. Gunawardena Breakdown of academic impact, for papers by Manjusha Nair Breakdown of academic impact, for papers by Véred Abitbol Breakdown of academic impact, for papers by Palle Bager Breakdown of academic impact, for papers by Susan Lerner Breakdown of academic impact, for papers by Mary Morgan Breakdown of academic impact, for papers by Nicolas Williet Breakdown of academic impact, for papers by José Pórtoles Breakdown of academic impact, for papers by Deborah D. Proctor
Rankless by CCL
2026